Latest Recurring Revenue News

Bell Financial Group reports a strong turnaround with a 17% rise in profit before tax for the 11 months to November 2025, driven by growth across key divisions and a robust second half.

Immutep has struck a strategic licensing deal with Dr. Reddy’s, granting rights to commercialise its novel cancer immunotherapy Eftilagimod Alfa across key emerging markets. The agreement includes a $20 million upfront payment and potential milestones exceeding $349 million.

Memphasys is intensifying its direct sales efforts for the Felix™ sperm-selection device across key Middle East IVF clinics, positioning for rapid market activation upon CE Mark approval expected early 2026.

TZ Limited has successfully raised $750,000 through a placement, boosted by strong shareholder support, while advancing key contracts with Microsoft and planning significant debt reduction.

Stakk Limited has secured a significant multi-year agreement with Panacea Financial, a U.S. neobank division backed by Peter Thiel, to provide its Embedded Finance technology. This partnership marks a strategic expansion into niche medical financial services.

RMA Global Limited reveals its strategic push into the US market, leveraging its Local Expert Marketing platform to capture a significant share of the real estate marketing sector.

Mach7 Technologies has inked a five-year subscription agreement with UnityPoint Health, marking the first commercial deployment of its new Flamingo Architecture and setting the stage for significant recurring revenue growth.

Ava Risk Group’s BQT Solutions has inked a five-year supply and co-development agreement with US-based UniKey Technologies, targeting the booming mobile credential access market with new NFC/BLE readers.

Veris Limited has completed the acquisition of Melbourne-based Mesh and a 50% stake in the Parsel digital platform, marking a strategic push into higher-margin digital advisory services.

Oneview Healthcare reported robust commercial growth in 2025, driven by new US client wins and the launch of its AI-powered care assistant, Ovie. The company enters 2026 with a confident outlook focused on expanding its US footprint and advancing digital health innovation.

Aspermont Limited reports its 37th consecutive quarter of subscription growth, launches its Mining-IQ data platform, and secures a landmark contract with Rio Tinto, signaling a strategic shift towards data-driven intelligence.

Singular Health has submitted a 510(k) premarket notification to the FDA for its enhanced 3DICOM MD Cloud platform, aiming to expand imaging capabilities and introduce a scalable, cloud-native solution for medical image management.